Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Transphorm, Inc.

Transphorm, Inc. (TGAN) Stock Overview

Explore Transphorm, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TGAN●NASDAQ
TechnologySemiconductors
$5.10
$0.34(7.14%)
U.S. Market is Open · 13:42

Transphorm, Inc. (TGAN)

Meyka AI Score

Z

Key Financials

Market Cap323.1M
P/E Ratio-9.11
EPS (TTM)$-0.70
ROE-1.24%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1.83

TGAN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Transphorm, Inc. (NASDAQ: TGAN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Transphorm, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TGAN on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $1.83 for the NASDAQ listing.

Key metrics behind Transphorm, Inc.'s NASDAQ-traded stock include a P/E ratio of -9.11 and a market capitalization of 323.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TGAN on the NASDAQ.

Price Performance (NASDAQ: TGAN)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
6.47%
6-Month Change
5.59%
Year-to-Date (YTD) Change
27.82%
1-Year Change
63.99%
3-Year Change
18.60%
5-Year Change
2.00%
All-Time (Max) Change
2.00%

Contact Information

https://www.renesas.com/products/power-discretes/gan-power-discretes
805 456 1300
75 Castilian Drive, Goleta, CA, 93117

Company Facts

1,280 Employees
IPO DateJul 29, 2020
CountryUS

Frequently Asked Questions